MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-02-0091180
Bilstein Life Sciences Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹30.83 Lakh
▲ 74% YoY
Net loss · FY 2023
₹34.99 Lakh
Net margin -113.5%
EBITDA · FY 2023
-₹34.68 Lakh
EBITDA margin -112.5%
Authorised capital
₹3 Lakh
Registered with MCA
Paid-up capital
₹3 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Employees · EPFO
6
Provident fund records
Directors on board
2
As per MCA filings
About Bilstein Life Sciences Private Limited
Data last updated:
Bilstein Life Sciences Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 March 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U74999TN2018PTC121522. Its GSTIN is 33AAHCB7175R1Z0 (Tamil Nadu).
The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors Rajakumar Velusamy and Arulprakasam A Bhuvaneswari.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Old No.8/6 New No.24/6 First Floor 2nd Street V.O.C. Nagar Anna Nagar, Chennai, Tamil Nadu, India – 600102.
As per the financials filed for FY 2023, the company reported a revenue of ₹30.83 Lakh, a growth of 74% compared to the previous year. For the same year it recorded a net loss of ₹34.99 Lakh (net margin -113.5%) and EBITDA of -₹34.68 Lakh (EBITDA margin -112.5%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years.
The company has about 6 employees on its provident fund (EPFO) records.
Bilstein Life Sciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0091180). For more details, the company can be reached via its website bilsteinpharma.com.
Company details
CIN U74999TN2018PTC121522
Registration Number 121522
Incorporation Date 19 March 2018
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
MSME Classification Micro
Udyam Registration UDYAM-TN-02-0091180
Recognitions & Rankings of Bilstein Life Sciences
Contact details
Bilstein Life Sciences Private Limited's registered office is in Chennai, Tamil Nadu. Its website is bilsteinpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressOld No.8/6 New No.24/6 First Floor 2nd Street V.O.C. Nagar Anna Nagar, Chennai, Tamil Nadu, India – 600102
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Bilstein Life Sciences Private Limited, buy the company report.
Comprehensive company report
Bilstein Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Bilstein Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Bilstein Life Sciences Private Limited, buy the company report.
Financials of Bilstein Life Sciences Private Limited
FY 2023 filings availableBilstein Life Sciences Private Limited reported revenue of ₹30.83 Lakh (up 74% YoY) for FY 2023.
Revenue · FY 2023
₹30.83 Lakh ▲ 74%
Net loss · FY 2023
₹34.99 Lakh margin -113.5%
EBITDA · FY 2023
-₹34.68 Lakh margin -112.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 74%
3 years · compounded
▲ 22%
EBITDA CAGR growth
1 year
▼ 16%
3 years · compounded
▼ 180%
Revenue has grown at a compounded annual rate (CAGR) of 22% over three years, including 74% growth in the latest year. EBITDA fell 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹34.68 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹34.99 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -112.5% | ||||
| Net Profit Margin | -113.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bilstein Life Sciences Private Limited, buy the company report.
Board of directors of Bilstein Life Sciences Private Limited
Bilstein Life Sciences has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajakumar Velusamy Also directs: Almuriat Health Care Private Limited | Director | 05 Aug 2021 | 5 Years 2 Months | Current |
| Arulprakasam A Bhuvaneswari | Director | 30 Jun 2021 | 5 Years 3 Months | Current |
Peer comparison
Bilstein Life Sciences Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bioeco Vendors India Private Limited | ₹31.13 Lakh (FY 2024) | 43.0% | Delhi, India | |||
| Viakos Pharmaceuticals Private Limited | ₹30.87 Lakh (FY 2024) | 71.0% | Mumbai, Maharashtra, India | |||
| Bilstein Life Sciences Private Limitedthis company | ₹30.83 Lakh (FY 2023) | -₹34.99 Lakh | -113.5% | 74.0% | 6 | Chennai, Tamil Nadu, India |
| Klyvus Private Limited | ₹30.8 Lakh (FY 2025) | 5.0% | Bangalore, Karnataka, India | |||
| Macnis Pharmaceuticals Private Limited | ₹30.55 Lakh (FY 2023) | 27.0% | Delhi, India | |||
| Massy Healthcare Private Limited | ₹30.46 Lakh (FY 2025) | -6.0% | Ambala Cantt, Haryana, India |
To see the full peer comparison of Bilstein Life Sciences Private Limited, buy the company report.
Auditor
Bilstein Life Sciences Private Limited is audited by ANGURAJ AND ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANGURAJ AND ASSOCIATES | FY 2022 | 015777S |
Shareholding
The shareholding of Bilstein Life Sciences Private Limited is on record for 2 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Bilstein Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Bilstein Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bilstein Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Bilstein Life Sciences Private Limited has a workforce of 6 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
Employee count
6
Active EPFO establishments
1
Employee growth
-25%
GST
Bilstein Life Sciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAHCB7175R1Z0 | Tamil Nadu | Active | 29 Mar 2018 |
To see the full GST registrations and return filing status of Bilstein Life Sciences Private Limited, buy the company report.
Recent activity
Bilstein Life Sciences Private Limited has 10 board changes on record since 2018: 6 appointments and 4 cessations. The latest: Mohd Iqbal Mohd Younus ceased to be Additional Director on 05 Aug 2021.
AGM
Bilstein Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Bilstein Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Chennai.
Ceased
Mohd Iqbal Mohd Younus ceased to be Additional Director.
Ceased
Panneerselvam Singaram ceased to be Director.
Appointed
Rajakumar Velusamy was appointed as Director.
Appointed
Arulprakasam A Bhuvaneswari was appointed as Director.
Ceased
Mohammd Zafarullah Sharief Abdullah Sharief ceased to be Director.
Ceased
Sugumar ceased to be Director.
Appointed
Mohd Iqbal Mohd Younus was appointed as Additional Director.
Appointed
Mohammd Zafarullah Sharief Abdullah Sharief was appointed as Director.
Appointed
Panneerselvam Singaram was appointed as Director.
Appointed
Sugumar was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Bilstein Life Sciences is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 March 2018 (8+ years old) and is registered under CIN U74999TN2018PTC121522.
Bilstein Life Sciences has 2 current directors:
- Rajakumar Velusamy - Director
- Arulprakasam A Bhuvaneswari - Director
The latest financial statements of Bilstein Life Sciences on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Bilstein Life Sciences is 33AAHCB7175R1Z0, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Bilstein Life Sciences is U74999TN2018PTC121522. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bilstein Life Sciences was incorporated on 19 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Bilstein Life Sciences by revenue are Bioeco Vendors India Private Limited, Viakos Pharmaceuticals Private Limited, Klyvus Private Limited, Macnis Pharmaceuticals Private Limited, Massy Healthcare Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Mohd Iqbal Mohd Younus ceased to be Additional Director on 05 Aug 2021. Panneerselvam Singaram ceased to be Director on 05 Aug 2021. Rajakumar Velusamy was appointed as Director on 05 Aug 2021. Bilstein Life Sciences has 10 board changes on record in total.
Yes, Bilstein Life Sciences is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-02-0091180).
Bilstein Life Sciences can be reached through the website bilsteinpharma.com. Its registered office is in Chennai, Tamil Nadu, India.
The registered office of Bilstein Life Sciences is at Old No.86 New No.246 First Floor 2nd Street V.O.C. Nagar Anna Nagar, Chennai, Tamil Nadu, India – 600102.